๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Botulinum toxin for refractory vocal tics

โœ Scribed by Stephen Salloway; Celia F. Stewart; Lisa Israeli; Ximena Morales; Steven Rasmussen; Andrew Blitzer; Mitchell F. Brain

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
350 KB
Volume
11
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Vocal tics in gilles de la tourette synd
Vocal tics in gilles de la tourette syndrome treated with botulinum toxin injections
โœ Michael R. Trimble; Renata Whurr; Gerald Brookes; Mary M. Robertson ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 628 KB

A PIG. 1. The axial TI-weighted magnetic resonance scan image of the biain, demonsuating bilateral paramedian thalamic lesions (A). A T1weighted image on the coronal plane (B) shows the Same lesions conilned to the thalamus. In summary, this report documents the association of isolated thalamic lesi

Botulinum toxin in the treatment of dyst
Botulinum toxin in the treatment of dystonic tics
โœ Dr. Joseph Jankovic ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 236 KB

## Abstract Botulinum toxin (BTX) injections provide effective treatment for a variety of disorders manifested by inappropriate muscle contractions, but its efficacy in the treatment of tics has not been previously studied. Ten male patients 13โ€“53 years of age who were diagnosed with Tourette's syn

Botulinum toxin injections for new onset
Botulinum toxin injections for new onset bilateral vocal fold motion impairment in adults
โœ Dale C. Ekbom; C. Gaelyn Garrett; Katherine C. Yung; Felicia L. Johnson; Cheryl ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 157 KB

## Abstract ## Objectives/Hypothesis: Review of clinical experience and results using botulinum toxin type A (BTX) for the management of adult patients with respiratory compromise due to new onset bilateral vocal fold motion impairment (BVFMI). ## Study Design: Retrospective case series. ## Met

New therapeutic indications for botulinu
New therapeutic indications for botulinum toxins
โœ Carla Cordivari; V. Peter Misra; Santiago Catania; Andrew J. Lees ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 204 KB

The efficacy of botulinum toxin (BTX) without systemic effects has led to the rapid development of applications in neuromuscular disorders, hyperactivity of sudomotor cholinergic-mediated glandular function, and pain syndromes. The successful use of BTX in conditions with muscle overactivity, such a